First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602

Tetsuji Terazawa,Takeshi Kato,Masahiro Goto,Daisuke Sakai,Yukinori Kurokawa,Toshio Shimokawa,Yoshihiro Matsubara and Taroh Satoh

BMC Cancer (2019) 19:623